|
1
|
Zhao H, Li M, Li L, Yang X, Lan G and
Zhang Y: MiR-133b is down-regulated in human osteosarcoma and
inhibits osteosarcoma cells proliferation, migration and invasion,
and promotes apoptosis. PLoS One. 8:e835712013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shimbo K, Miyaki S, Ishitobi H, Kato Y,
Kubo T, Shimose S and Ochi M: Exosome-formed synthetic microRNA-143
is transferred to osteosarcoma cells and inhibits their migration.
Biochem Biophys Res Commun. 445:381–387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pierz KA, Womer RB and Dormans JP:
Pediatric bone tumors: osteosarcoma ewing’s sarcoma, and
chondrosarcoma associated with multiple hereditary
osteochondromatosis. J Pediatr Orthop. 21:412–418. 2001.
|
|
4
|
Yang C, Hou C, Zhang H, Wang D, Ma Y,
Zhang Y, Xu X, Bi Z and Geng S: miR-126 functions as a tumor
suppressor in osteosarcoma by targeting Sox2. Int J Mol Sci.
15:423–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie ZG, Xie Y and Dong QR: Inhibition of
the mammalian target of rapamycin leads to autophagy activation and
cell death of MG63 osteosarcoma cells. Oncol Lett. 6:1465–1469.
2013.PubMed/NCBI
|
|
6
|
Xie P: TRAF molecules in cell signaling
and in human diseases. J Mol Signal. 8:72013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wajant H, Henkler F and Scheurich P: The
TNF-receptor-associated factor family: scaffold molecules for
cytokine receptors, kinases and their regulators. Cell Signal.
13:389–400. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ha H, Han D and Choi Y: TRAF-mediated
TNFR-family signaling. Curr Protoc Immunol. Chapter 11(Unit
11.9D)2009.PubMed/NCBI
|
|
9
|
Arron JR, Walsh MC and Choi Y:
TRAF-mediated TNFR-family signaling. Curr Protoc Immunol. Chapter
11(Unit 11.9D)2002.PubMed/NCBI
|
|
10
|
Tomasetto C, Regnier CH and Rio MC: TRAF-4
expression in breast carcinomas. Am J Pathol. 153:2007–2008. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Camilleri-Broët S, Cremer I, Marmey B,
Comperat E, Viguié F, Audouin J, Rio MC, Fridman WH, Sautès-Fridman
C and Régnier CH: TRAF4 overexpression is a common characteristic
of human carcinomas. Oncogene. 26:142–147. 2007.PubMed/NCBI
|
|
12
|
Marinis JM, Homer CR, McDonald C and
Abbott DW: A novel motif in the Crohn’s disease susceptibility
protein, NOD2, allows TRAF4 to down-regulate innate immune
responses. J Biol Chem. 286:1938–1950. 2011.PubMed/NCBI
|
|
13
|
Qin GQ, He HC, Han ZD, Liang YX, Yang SB,
Huang YQ, Zhou L, Fu H, Li JX, Jiang FN and Zhong WD: Combined
overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical
recurrence-free survival in patients with prostate cancer. Onco
Targets Ther. 7:137–146. 2014.PubMed/NCBI
|
|
14
|
Tayarani-Najaran Z, Asili J, Aioubi E and
Emami SA: Growth inhibition and apoptosis induction of Salvia
chloroleuca on MCF-7 breast cancer cell line. Iran J Pharm Res.
12:789–799. 2013.
|
|
15
|
Zhang B, Lu Z, Hou Y, Hu J and Wang C: The
effects of STAT3 and Survivin silencing on the growth of human
bladder carcinoma cells. Tumour Biol. 35:5401–5407. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meng Q, Zheng M, Liu H, Song C, Zhang W,
Yan J, Qin L and Liu X: TRAF6 regulates proliferation, apoptosis,
and invasion of osteosarcoma cell. Mol Cell Biochem. 371:177–186.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Huang T, Jiang G, Gong W, Qian H and
Zou C: Synergistic apoptotic effect of crocin and cisplatin on
osteosarcoma cells via caspase induced apoptosis. Toxicol Lett.
221:197–204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo F, Sun A, Wang W, He J, Hou J, Zhou P
and Chen Z: TRAF1 is involved in the classical NF-κB activation and
CD30-induced alternative activity in Hodgkin’s lymphoma cells. Mol
Immunol. 46:2441–2448. 2009.
|
|
19
|
Zheng H, Liu C, Ou Y, Zhang Y and Fu X:
Total saponins of Panax notoginseng enhance VEGF and
relative receptors signals and promote angiogenesis derived from
rat bone marrow mesenchymal stem cells. J Ethnopharmacol.
147:595–602. 2013.
|
|
20
|
Yang WT and Zheng PS: Promoter
hypermethylation of KLF4 inactivates its tumor suppressor function
in cervical carcinogenesis. PLoS One. 9:e888272014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garrington GE, Scofield HH, Cornyn J and
Hooker SP: Osteosarcoma of the jaws. Analysis of 56 cases. Cancer.
20:377–391. 1967. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Geller DS and Gorlick R: Osteosarcoma: a
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
23
|
Tomasetto C, Régnier C, Moog-Lutz C,
Mattei MG, Chenard MP, Lidereau R, Basset P and Rio MC:
Identification of four novel human genes amplified and
overexpressed in breast carcinoma and localized to the q11-q21.3
region of chromosome 17. Genomics. 28:367–376. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fleckenstein DS, Dirks WG, Drexler HG and
Quentmeier H: Tumor necrosis factor receptor-associated factor
(TRAF) 4 is a new binding partner for the p70S6 serine/threonine
kinase. Leuk Res. 27:687–694. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sax JK and El-Deiry WS: Identification and
characterization of the cytoplasmic protein TRAF4 as a
p53-regulated proapoptotic gene. J Biol Chem. 278:36435–36444.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Esparza EM and Arch RH: TRAF4 functions as
an intermediate of GITR-induced NF-κB activation. Cell Mol Life
Sci. 61:3087–3092. 2004.PubMed/NCBI
|
|
27
|
Beg AA and Baltimore D: An essential role
for NF-kappaB in preventing TNF-alpha-induced cell death. Science.
274:782–784. 1996. View Article : Google Scholar : PubMed/NCBI
|
